Phase
Startup
Asgard Therapeutics
Asgard Therapeutics was founded in 2018 as a spin-off from Lund University aiming to advance cancer immunotherapies by developing a paradigm-shifting gene therapy – TrojanDC. Driven by the urgent need for new cost-effective immunotherapies consistently effective in a broad range of patients, Asgard is developing the world’s first cancer immunotherapy based on direct cell reprogramming, forcing cancer cells to become immunogenic and unleashing the immune system against cancer.
Cristiana Pires holds a degree in Pharmaceutical Sciences and PhD in Cell Reprogramming. She founded Asgard Therapeutics in 2018 together with the other two inventors of TrojanDC, Associate Professor Filipe Pereira and Fábio Rosa, MSc. Now, by combining her pharmaceutical and scientific background with entrepreneurship experience, Cristiana is motivated to bring TrojanDC to the patients.
Did you know?
Asgard’s scientific founders are from Portugal and decided to honor the Swedish affiliation by choosing a name inspired by the Norse Mythology.
Non-invasive cardiac pressure monitoring device
Amplify the efficacy of pharmaceutical treatments
Medicines for acute systemic inflammatory diseases
Cancer immunotherapies based in cell reprogramming
A "check-in buddy" for the elderly
Cell factories for dairy processing
Digital service for patients
Digital communication tool for titrating medicine
Mobile systems for movement analysis
Innovative solutions for better health care
Medical device that reduces pain during vein operation
Prebiotics for irritable bowel syndrome
A reusable, user-friendly, and sustainable pregnancy test
Digital assistive device for post-surgical rehabilitation
Nanotechnology based infection control
Bio-based vegan coating for fruits and vegetables
Short chain fatty acids can be delivered to the colon
Equipment that improves the function of cultivated cells
Medtech solution for preventing pressure ulcers
More info soon
Gene editing analysis solution
Stroke detection device
An innovative digital medical service for men over 40
Safer medical needles for prostate biopsy
